SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the D... PR Newswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on SRPT
    SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT
    5:55p ET July 18 '25 PR Newswire

    The DJS Law Groupreminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws.

    Shareholderswho purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.

    CASE DETAILS:The complaint alleges that the Company made false and misleading statements to the market concerning Sarepta leading investors to believe that its ELEVIDYS therapy was both safe and had potential for approval in wider applications. The Company allegedly misled the market about its revenue outlook on ELEVIDYS. The Company also positioned the therapy as having strong growth potential due to a lack of hindrances to broader use.

    If you are a shareholder who suffered a loss,contact us to participate.

    WHY DJS LAW GROUP?DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

    This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

    CONTACT:

    David J. Schwartz

    DJS Law Group

    274 White Plains Road, Suite 1

    Eastchester, NY 10709

    Phone: 914-206-9742

    Email:David@djslawllp.com

    https://c212.net/c/img/favicon.png?sn=LA33406&sd=2025-07-18

    View original content:https://www.prnewswire.com/news-releases/srpt-shareholders-have-the-right-to-lead-the-sarepta-therapeutics-inc-securities-lawsuit---contact-the-djs-law-group-before-the-final-deadline---srpt-302508885.html

    SOURCE DJS Law Group LLP

    https://rt.newswire.ca/rt.gif?NewsItemId=LA33406&Transmission_Id=202507181755PR_NEWS_USPR_____LA33406&DateId=20250718

    COMTEX_467431201/1005/2025-07-18T17:55:24

    SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Se...
    5:54p ET July 18 '25 PR Newswire
    ROSEN, LEADING INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc...
    5:30p ET July 18 '25 ACCESSWIRE
    Investors Urged to Contact Levi & Korsinsky for Information Before Au...
    3:50p ET July 18 '25 Newsfile Corp
    SRPT BREAKING NEWS: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Announce...
    3:14p ET July 18 '25 GlobeNewswire
    ROSEN, A LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Inve...
    2:10p ET July 18 '25 Newsfile Corp
    SRPT Investors Have the Opportunity to Lead the Sarepta Securities Fr...
    11:45a ET July 18 '25 Newsfile Corp
    Levi & Korsinsky Announces the Filing of a Securities Class Action on...
    8:45a ET July 18 '25 PR Newswire
    SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Se...
    8:11a ET July 18 '25 GlobeNewswire
    SRPT INVESTOR DEADLINE: Sarepta Therapeutics, Inc. Investors with Sub...
    6:00a ET July 18 '25 PR Newswire
    SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Se...
    6:06p ET July 17 '25 PR Newswire

    Market data provided by News provided by